2022TiP Stereotactic treatment with neoadjuvant radiotherapy and enfortumab vedotin: A phase I/II study for localized, cisplatin ineligible, muscle invasive bladder cancer (STAR-EV)

Authors:
  • TZT. Zhang
    T. Zhang
  • SWS. Woldu
    S. Woldu
  • QQQ. Qin
    Q. Qin
  • SCS. Cole
    S. Cole
  • WAW. Arafat
    W. Arafat
  • CJC. Jiang
    C. Jiang
  • JWJ. Wang
    J. Wang
  • KCK. Courtney
    K. Courtney
  • ADA. DeVilbiss
    A. DeVilbiss
  • RPR. Ploski
    R. Ploski
  • RHR. Hannan
    R. Hannan
  • DYD. Yang
    D. Yang

Abstract
No abstract available